One woman a week suffers a deadly IVF side effect

by | Dec 17, 2018 | UK Fertility News


One woman a week suffers a deadly IVF side effect

by | Dec 17, 2018 | UK Fertility News

One woman a week suffers a deadly IVF side effect: Ovary stimulation syndrome hits a seven-year high as hopeful mothers battle kidney failure, blood clots and breathing problems

  • Almost 800 women have been rushed to hospital in the past five years
  • Ovary stimulation syndrome causes ovaries to expand dangerously, can lead to blood clots
  • High dose drugs mean women are releasing up to 71 eggs at a time

By Victoria Allen Science Correspondent For The Daily Mail

Women are being struck down by a painful and potentially fatal side effect of IVF at a rate of one a week.

Severe illness caused by powerful IVF drugs has hit a seven-year high, with almost 800 women rushed to hospital in the last five years.

Ovarian hyperstimulation syndrome, or OHSS, causes women’s ovaries to expand dangerously and in severe cases can leave victims fighting to breathe with blood clots in their lungs.

A new report from a fertility regulator reveals 52 women were diagnosed with severe or critical OHSS in 2017-18.

The statistics raise concern that fertility clinics are giving women high doses of drugs to boost their ovaries so they produce more than the normal one egg a month.

Separate statistics revealed to Parliament earlier this month show 792 cases in which women needed hospital treatment for OHSS between October 2013 and October of this year.

Professor Geeta Nargund, lead consultant of reproductive medicine at St George’s Hospital in London and medical director of CREATE Fertility, said:

‘IVF is already an emotionally and physically demanding process for women, and it is important that we do everything possible to reduce the risk of hospitalisation with OHSS for women.’

The latest report, from fertility regulator the Human Fertilisation and Embryology Authority, states that around a third of women suffer from mild OHSS, which can be treated at home with painkillers.

What is ovarian hyperstimulation syndrome?

Ovarian hyperstimulation syndrome (OHSS) can affect women undergoing IVF or other fertility procedures.

It occurs when they take injectable hormones to stimulate the development of eggs in the ovaries.

Too much hormone medication can cause the ovaries to become swollen and painful. In severe cases it can lead to rapid weight gain, abdominal pain, vomiting and shortness of breath.

In rare cases, OHSS occurs after taking oral fertility treatments or even just spontaneously.Symptoms typically begin within ten days of taking injectable medications. In mild cases they can include:

  • Moderate abdominal pain
  • Bloating or an increased waist size
  • Nausea and vomiting
  • Diarrhoea
  • Sudden weight gain of more than 6.6lbs (3kg)

These symptoms often ease within a week without treatment.

In severe cases, symptoms include:

  • Rapid weight gain of 33-44lbs (15-20kg) within five-ten days
  • Severe abdominal pain, nausea and vomiting
  • Blood clots in the legs
  • Reduced urination
  • Shortness of breath
  • Tight or enlarged abdomen

In around 1-2 per cent of cases, OHSS can be life-threatening and lead to:

  • Fluid in the abdomen or chest
  • Blood clots
  • Kidney failure
  • Ovary twisting
  • Rupture of an ovarian cyst, leading to bleeding
  • Breathing problems
  • Miscarriage
  • Death

Severe sufferers may require IV fluids in hospital and drugs to suppress their ovarian activity.

Surgery may be necessary if an ovarian cyst bursts, as well as anticoagulants if clots have occurred.

OHSS’ exact cause is unknown but is thought to be due a hormone called HCG, which triggers the release of an egg.

Ovarian blood vessels react abnormally to HCG and begin to leak fluid, which causes swelling that can move into the abdomen.

Source: Mayo Clinic 

But 52 women in 2017/18 had the more severe version, which can cause blood clots in the legs and lungs, dehydration as fluid builds up in the abdomen, and difficulty breathing as it builds up in the chest.

The condition can be fatal, although there have been no deaths from OHSS reported by clinics.

The fertility regulator says women who have OHSS are among the ‘grade B’ incidents which cause serious harm. These incidents within IVF clinics in the UK, also including equipment failures, have almost doubled, from 62 in 2016/17 to 116 in 2017/18.

A patient survey by the regulator shows almost two-thirds of people who have private IVF pay more than they expect to, raising more concerns about the £320 million British IVF industry.

Separate figures on OHSS released in answer to a Parliamentary question last month show there were 75 severe cases up to November 14 this year.

This is higher than any figure recorded in the previous seven years and more than double the 34 cases seen in 2014.

While some experts believe more eggs means a better chance they will be successfully fertilised and lead to healthy babies, critics say producing too many is dangerous.

It is feared women are being pumped full of drugs, with figures showing some have produced more than 71 eggs for IVF.

Dr Neville Cobbe, a biochemist formerly from the University of Liverpool, with an interest in OHSS, said:

‘Surely it is not physiologically normal for our species to produce over 40 eggs at a time, let alone as many as 70 eggs in several recorded treatment cycles.

‘It is well established in the research literature that the incidence of hospital admission due to ovarian hyperstimulation syndrome increases significantly if more than 20 eggs develop.

‘Why is the HFEA not more concerned about the hundreds of women who have had over 40 eggs collected per cycle?’

Sally Cheshire, chair of the HFEA, said:

‘The UK’s fertility sector shows a high level of professionalism, reflected by fewer than 600 incidents occurring out of more than 80,000 treatment.’

But she added: ‘Clinical and administrative errors can cause patients distress and more work must be done in clinics to prevent incidents occurring, including cases of OHSS.

‘We are working closely with partners, the professional bodies and clinics to ensure the systems for the prevention and reporting of incidents, including OHSS, are as rigorous as possible.’


More articles

Surrogacy UK welcomes Law Commission Consultation Paper on Reforming UK’s Outdated Surrogacy Laws

On 6th June, at a conference entitled ‘Reforming Surrogacy Laws: Future Directions and Possibilities’, the Law Commission of England and Wales and the Scottish Law Commission will launch their public consultation on reforming the UK’s outdated surrogacy laws. Surrogacy UK has long campaigned for legal reform and was consulted by the Law Commission in the preparation of their proposals.

Domicile and Surrogacy: The 5 W’s

“Where is your home?” seems like a simple question. But in our multi-cultural society, that is not always so. For intended parents in a surrogacy arrangement, it is one of the most important questions to ask.

Surrogacy UK Code of Practice update

The HFEA (Human Fertilisation and Embryology Authority) govern and regulate all fertility treatments that take place in licensed fertility centres throughout the UK. The code of practice has recently been updated and we are awaiting the official issue of the 9th edition so that we can implement this into our clinical practice.

NHS Funding and Surrogacy

There’s been much discussion in recent days about the story in the Daily Mail about a same sex male couple in the UK who have received public funding for IVF treatment to try to create embryos using their own gametes and donor eggs.

Fertility regulator calls for clinics to be more open about treatment add-ons

The HFEA, the UK fertility regulator, has called for a change in how patients are offered optional fertility treatment add-ons.

Surrogacy Survey 2018 Results

Surrogates do not support calls for commercial surrogacy in the UK. Over 70 per cent of surrogates in the UK believe they should only be allowed to claim expenses when they carry a child for another couple, the UK’s largest ever survey into surrogacy has found.

Surrogacy UK welcomes individuals who want to start families

Surrogacy UK welcomes individuals who want to start families as UK Parliament votes to end three decades of discrimination.

Research findings from a longitudinal study of surrogacy families in the UK

Around the year 2000, a group of researchers, headed by Professor Susan Golombok, began a study of families created using surrogacy. I have worked on the project from its beginnings, when children in the study were one year old infants. Since then, our team has revisited the families five times and last saw them when the children were aged 14.

Host or Straight Surrogacy – Choosing your path

If you’re reading this then you will have most likely either made the choice that surrogacy is the path to parenthood that you wish to take, or you are close to taking that first big step.